BigHat Biosciences
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
$75MSeries C
ParticipantQC
Quadrille Capital
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Biotech · Jul 27, 2026
Quadrille Capital is a technology and healthcare investment manager whose own feed confirms Reco and Adonis.
Recorded funding activity
Reco secures SaaS systems and agents. Adonis helps providers recover reimbursement, while BigHat engineers antibody medicines. These companies address different security, financial and biological problems.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $75M 1 disclosed · full round size, not this investor’s share